Skip to main content
Signal8

BENZENO SHARON

SEC insider (Form 3/4/5 filer). CIK 0001780854. Chief Commercial Ofc Imm Med at Adaptive Biotechnologies Corp (ADPT). 26 reported Form 4/5 transactions since Sep 2024; latest on Jun 29, 2026. Located in SEATTLE, WA.

Companies BENZENO SHARON has filed insider reports for

  • Adaptive Biotechnologies Corp (ADPT): Officer, Chief Commercial Ofc Imm Med
BENZENO SHARON profile photo

BENZENO SHARON

CIK: 0001780854

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)8 (30.8%)

Position reduction

Option Exercises (M)16 (61.5%)

Derivative conversions

Awards (A)2 (7.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Adaptive Biotechnologies Corp logo
ADPT

Adaptive Biotechnologies Corp

Officer

Discretionary Trading P&L

Holdings

Transaction History (26 total)

  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Jun 29, 2026
    Exercise
    Direct
    24.9K shares at avg. $3.99$100K
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Jun 29, 2026
    Sale
    Direct
    154.8K shares at avg. $21.14$3.3M
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Jun 29, 2026
    Exercise
    Direct
    24.9K shares at avg. $8.46$211K
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Jun 29, 2026
    Exercise
    Direct
    51.6K shares at avg. $8.12$419K
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Jun 29, 2026
    Exercise
    Direct
    1.8K shares at avg. $12.14$22K
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Jun 26, 2026
    Sale
    Direct
    11K shares at avg. $21.00$232K
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Jun 26, 2026
    Exercise
    Direct
    11K shares at avg. $12.14$134K
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Mar 11, 2026
    Sale
    Direct
    63.1K shares at avg. $13.17$831K
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Mar 4, 2026
    Award
    Direct
    39.1K shares-
  • Adaptive Biotechnologies Corp logo
    ADPT

    Adaptive Biotechnologies Corp

    Dec 4, 2025
    Exercise
    Direct
    4.2K shares at avg. $8.46$35K

1-10 of 26